Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 856,745 | 1,351,991 | 465,624 | 473,410 | 129,239 |
| Marketable Securities | 292,357 | 199,692 | 168,353 | 179,634 | 484,163 |
| Inventories | 1,213,201 | 1,147,861 | 1,267,954 | 1,296,733 | 1,300,104 |
| Other current assets | 2,104,342 | 2,113,780 | 1,816,996 | 1,751,431 | 1,633,810 |
| TOTAL | $4,547,942 | $4,894,681 | $3,773,528 | $3,770,443 | $3,547,317 |
| Non-Current Assets | |||||
| PPE Net | 2,709,379 | 2,490,977 | 2,364,522 | 2,539,201 | 2,497,975 |
| Other Non-Current Assets | 60,973 | 38,459 | 50,051 | 52,393 | 55,939 |
| TOTAL | $2,770,352 | $2,529,436 | $2,414,572 | $2,591,595 | $2,553,914 |
| Total Assets | $7,318,293 | $7,424,117 | $6,188,100 | $6,362,037 | $6,101,231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 347,076 | 1,013,254 | 2,096,067 | 200,217 | 177,462 |
| Accounts payable and accrued liabilities | 791,082 | 625,703 | 530,842 | 497,736 | 1,438,988 |
| TOTAL | $2,964,214 | $3,490,918 | $3,969,181 | $1,730,848 | $1,616,450 |
| Non-Current Liabilities | |||||
| Long Term Debt | 822,350 | 829,833 | 1,371,089 | 3,225,927 | 3,300,413 |
| Other Non-Current Liabilities | 716,039 | 673,037 | 591,510 | 353,654 | 389,645 |
| TOTAL | $1,629,067 | $1,609,372 | $2,049,050 | $3,714,307 | $3,801,937 |
| Total Liabilities | $4,593,280 | $5,100,290 | $6,018,231 | $5,445,155 | $5,418,387 |
| Shareholders' Equity | |||||
| Common Shares | 368,963 | 349,092 | 273,004 | N/A | N/A |
| Retained earnings | 1,494,614 | 1,193,716 | 1,254,304 | 782,156 | 570,966 |
| Other shareholders' equity | 764,504 | 673,037 | -1,443,890 | 0 | 0 |
| TOTAL | $2,634,335 | $2,217,324 | $83,418 | $782,156 | $570,966 |
| Total Liabilities And Equity | $7,227,616 | $7,317,614 | $6,101,649 | $6,227,312 | $5,989,352 |